Sponsors

C. difficile: the complete picture

Inverness Medical has introduced its new TECHLAB C. DIFF QUIK CHEK COMPLETE rapid test as an in vitro diagnostic aid for Clostridium difficileassociated disease (CDAD).

C. difficile is responsible for the most common form of hospitalacquired diarrhoea and antibioticassociated colitis. Although primarily a hospital-acquired disease, C. difficile infection is occurring increasingly in community out-patient settings. This is causing a major problem in hospitals and the community because the number of patients at risk of C. difficile infection is substantial. Highly infectious and extremely dangerous in the immunocompromised or elderly patient, C. difficile infection can be life threatening. The test provides results in less than 30 minutes from faecal samples, enabling rapid diagnosis and initiation of appropriate patient management. Patients can be isolated at an earlier stage, reducing the risk of crosscontamination and widespread outbreaks. In addition, the new TECHLAB C. DIFF QUIK CHEK COMPLETE test detects toxigenic and non-toxigenic strains, including the new hypervirulent C. difficile strain BI/NAP1/027 which is causing outbreaks of increasing severity and mortality across Europe and North America.

www.invernessmedical.com

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026

Microbiology Society Annual Conference 2026

ICC Belfast, Northern Ireland
13 - 16 April, 2026